scroll to top
0

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "hypertension"

1 - 10 of 570,069 results for
 "hypertension"
Results per page:

Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR).

Publication Type: Academic Journal

Source(s): The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation [J Heart Lung Transplant] 2022 Dec; Vol. 41 (12), pp. 1808-1818. Date of Electronic Publication: 2022 Aug 28.

Abstract: Background: Routine long-term anticoagulation in pulmonary arterial hypertension (PAH) is controversial. To date, anticoagulation has been found to be beneficial or neutral in idiopathic disease (IPAH) and neutral-to-harmful in connective tissue diseas...

View details

Exercise-induced pulmonary hypertension in hypertrophic cardiomyopathy: a combined cardiopulmonary exercise test-echocardiographic study.

Publication Type: Academic Journal

Source(s): The international journal of cardiovascular imaging [Int J Cardiovasc Imaging] 2022 Nov; Vol. 38 (11), pp. 2345-2352. Date of Electronic Publication: 2022 Jun 28.

Abstract: Pulmonary arterial hypertension (PAH), documented in a significant portion of hypertrophic cardiomyopathy (HCM) patients, has been shown to adversely impact prognosis. In most HCM patients congestive symptoms are consistently elicited by exercise, thus...

View details

Evaluating Riociguat in the Treatment of Pulmonary Arterial Hypertension: A Real-World Perspective.

Publication Type: Academic Journal

Source(s): Vascular health and risk management [Vasc Health Risk Manag] 2022 Oct 20; Vol. 18, pp. 823-832. Date of Electronic Publication: 2022 Oct 20 (Print Publication: 2022).

Abstract: Pulmonary hypertension (PH) is a broad term describing the mean pulmonary artery pressure, as measured by right heart catheterization, exceeds 20mmHg. Pulmonary arterial hypertension (PAH) exists when PH is accompanied by a normal wedge pressure and el...

View details

Interest of TAPSE/sPAP ratio for noninvasive pulmonary arterial hypertension risk assessment.

Publication Type: Academic Journal

Source(s): The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation [J Heart Lung Transplant] 2022 Dec; Vol. 41 (12), pp. 1761-1772. Date of Electronic Publication: 2022 Sep 14.

Abstract: Background: Although ventriculoarterial coupling is associated with better survival in pulmonary arterial hypertension (PAH), existing PAH risk assessment method has not considered echocardiographic criteria of right ventricular to pulmonary artery cou...

View details

Risky business: a single-centre cross-sectional analysis of calculated cardiovascular risk in patients with primary aldosteronism and essential hypertension.

Publication Type: Academic Journal

Source(s): BMJ open [BMJ Open] 2022 Nov 14; Vol. 12 (11), pp. e062406. Date of Electronic Publication: 2022 Nov 14.

Abstract: Objectives: Primary aldosteronism (PA), the most common endocrine cause of hypertension, is associated with a higher risk of cardiovascular disease (CVD) than blood pressure (BP)-matched essential hypertension (EH). We aimed to compare the calculated r...

View details

Impact of T2DM on right ventricular systolic dysfunction and interventricular interactions in patients with essential hypertension: evaluation using CMR tissue tracking.

Publication Type: Academic Journal

Source(s): Cardiovascular diabetology [Cardiovasc Diabetol] 2022 Nov 09; Vol. 21 (1), pp. 238. Date of Electronic Publication: 2022 Nov 09.

Authors:

Abstract: Background: Previous studies reported that there was right ventricular (RV) systolic dysfunction in patients with hypertension. The aim of this study was to evaluate the impact of type 2 diabetes mellitus (T2DM) on RV systolic dysfunction and intervent...

View details

Non-Muscle MLCK Contributes to Endothelial Cell Hyper-Proliferation through the ERK Pathway as a Mechanism for Vascular Remodeling in Pulmonary Hypertension.

Publication Type: Academic Journal

Source(s): International journal of molecular sciences [Int J Mol Sci] 2022 Nov 07; Vol. 23 (21). Date of Electronic Publication: 2022 Nov 07.

Abstract: Pulmonary arterial hypertension (PAH) is characterized by endothelial dysfunction, uncontrolled proliferation and migration of pulmonary arterial endothelial cells leading to increased pulmonary vascular resistance resulting in great morbidity and poor...

View details

Contemporary risk scores predict clinical worsening in pulmonary arterial hypertension - An analysis of FREEDOM-EV.

Publication Type: Academic Journal

Source(s): The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation [J Heart Lung Transplant] 2022 Nov; Vol. 41 (11), pp. 1572-1580. Date of Electronic Publication: 2022 Aug 15.

Abstract: Background: Risk scores integrate clinical variables emphasizing symptoms, exercise capacity, and measures of cardiac strain to predict clinical outcome better than any single value in pulmonary arterial hypertension (PAH). Risk scores have demonstrate...

View details

m 6 A Modification-mediated GRAP Regulates Vascular Remodeling in Hypoxic Pulmonary Hypertension.

Publication Type: Academic Journal

Source(s): American journal of respiratory cell and molecular biology [Am J Respir Cell Mol Biol] 2022 Nov; Vol. 67 (5), pp. 574-588.

Authors:

Abstract: Pulmonary arterial hypertension (PAH) is characterized by pulmonary vascular remodeling induced by human pulmonary arterial smooth muscle cell (HPASMC) proliferation, migration, and apoptosis resistance. m 6 A ( N 6 -methyladenosine) is the mo...

View details

Outcome of mean pulmonary arterial pressure-based intensive treatment for patients with pulmonary arterial hypertension.

Publication Type: Academic Journal

Source(s): Journal of cardiology [J Cardiol] 2022 Nov; Vol. 80 (5), pp. 432-440. Date of Electronic Publication: 2022 May 12.

Abstract: Background: Mean pulmonary arterial pressure (mPAP) has not been recognized as a therapeutic target for pulmonary arterial hypertension (PAH). However, previous reports demonstrated that the survival of patients with some types of pulmonary hypertensio...

View details
sponsored